Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -145,224 | -25,751 | 73,602 | -109,781 | -325,991 |
| Depreciation Amortization | -27,226 | -17,160 | -7,054 | 2,194 | 8,746 |
| Accounts payable and accrued liabilities | 2,431 | 4,512 | 8,472 | 3,698 | 2,274 |
| Other Working Capital | -289,926 | -295,775 | -291,368 | 21,578 | -24,030 |
| Other Operating Activity | 101,954 | 74,840 | 44,377 | 23,509 | 94,285 |
| Operating Cash Flow | $-357,991 | $-259,334 | $-171,971 | $-58,802 | $-244,716 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,939 | -10,704 | -8,636 | -2,786 | -17,833 |
| Purchase Of Investment | -1,813,700 | -1,399,982 | -901,841 | -523,714 | -1,115,040 |
| Sale Of Investment | 2,075,947 | 1,586,947 | 985,829 | 433,785 | 991,486 |
| Investing Cash Flow | $249,308 | $176,261 | $75,352 | $-92,715 | $-141,387 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,820 | 13,115 | 10,623 | 1,604 | 14,455 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 296,215 |
| Financing Cash Flow | $17,820 | $13,115 | $10,623 | $1,604 | $310,670 |
| Beginning Cash Position | 219,544 | 219,544 | 219,544 | 219,544 | 294,977 |
| End Cash Position | 128,681 | 149,586 | 133,548 | 69,631 | 219,544 |
| Net Cash Flow | $-90,863 | $-69,958 | $-85,996 | $-149,913 | $-75,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -357,991 | -259,334 | -171,971 | -58,802 | -244,716 |
| Capital Expenditure | -12,939 | -10,704 | -8,636 | -2,786 | -17,833 |
| Free Cash Flow | -370,930 | -270,038 | -180,607 | -61,588 | -262,549 |